Header Logo

Connection

VIVEK SUBBIAH to MAP Kinase Kinase Kinase 1

Back to Details
This is a "connection" page, showing publications VIVEK SUBBIAH has written about MAP Kinase Kinase Kinase 1.
VIVEK SUBBIAH
Connection Strength
0.150
MAP Kinase Kinase Kinase 1
  1. Phase Ib/II Study of the Safety and Efficacy of Combination Therapy with Multikinase VEGF Inhibitor Pazopanib and MEK Inhibitor Trametinib In Advanced Soft Tissue Sarcoma. Clin Cancer Res. 2017 08 01; 23(15):4027-4034.
    View in: PubMed
    Score: 0.150
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.